Litigation Details for AMGEN INC. v. EMCURE PHARMACEUTICALS LTD. (D.N.J. 2018)
✉ Email this page to a colleague
AMGEN INC. v. EMCURE PHARMACEUTICALS LTD. (D.N.J. 2018)
Docket | ⤷ Sign Up | Date Filed | 2018-06-28 |
Court | District Court, D. New Jersey | Date Terminated | 2020-05-28 |
Cause | 15:1126 Patent Infringement | Assigned To | Michael Andre Shipp |
Jury Demand | None | Referred To | Douglas Arpert |
Patents | 10,092,541; 6,962,940; 7,427,638; 7,893,101; 9,872,854 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in AMGEN INC. v. EMCURE PHARMACEUTICALS LTD.
Biologic Drugs cited in AMGEN INC. v. EMCURE PHARMACEUTICALS LTD.
The biologic drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .
Details for AMGEN INC. v. EMCURE PHARMACEUTICALS LTD. (D.N.J. 2018)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2019-04-04 | 23 | Amended Complaint | (“the ’854 Patent”), and 10,092,541 (“the ’541 Patent”) (collectively, “the Patents-in-Suit”). … United States Patent Nos. 7,427,638 (“the ’638 Patent”), 7,893,101 (“the ’101 Patent”), 9,872,854 (…infringement of the ’541 Patent in addition to the ’638 Patent and the ’854 Patent, on November 8, 2018… This is a civil action for patent infringement arising under the patent laws of the United States,… This is a civil action for patent infringement arising under the patent laws of the United States, | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |